课题基金 / 基金详情

Access to Liver Transplantation for Patients with Primary Sclerosing Cholangitis

Access to Liver Transplantation for Patients with Primary Sclerosing Cholangitis
原发性硬化性胆管炎患者获得肝移植的机会
批准号:
8267243
负责人:
David Seth Goldberg
金额:
$5.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-03 至 2012-06-30

项目摘要

项目成果

David Seth Goldberg的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):原发性硬化性胆管炎(PSC)是一种慢性肝病,无法治疗,如果不进行肝移植,是一种致命的疾病。与其他终末期肝病患者相比,PSC患者面临独特的并发症,包括胆管癌(CCA)、胆管狭窄引起的胆管炎和并发症(如伴随炎症性肠病引起的结肠癌)。2002年2月27日建立的当前肝脏分配模型依赖于患者的终末期肝病模型(MELD)评分,该评分考虑了患者的血清INR、肌酐和胆红素。MELD评分对INR和肌酐的权重更大,尽管PSC患者的胆红素不成比例地升高。这一事实,沿着MELD数据元素未捕获CCA等并发症的事实,使我们相信MELD评分可能使PSC患者处于生存劣势。如果这是真的,那么这可能成为改变肝脏分配政策的基础。对于等待名单上的PSC患者,他们的死亡风险可能更高,原因有两个。对于PSC患者,给定MELD评分的死亡风险较高,或者在PSC患者中,MELD评分上升较慢,使患者不太可能接受移植,从而暴露于临床恶化和从等待名单中删除的风险的持续时间较长。我们的第一个目标将从三个方面解决这个主要的研究问题。我们将开发两个考克斯比例风险模型,一个考虑患者在等待名单上的所有MELD评分,另一个仅调整上市时的MELD。我们还将进行逻辑回归,以评价死亡与移植的临床重要结局。我们的第二个目标是确定潜在的肝移植受者因临床恶化而从等待名单中删除的频率,其中退出的原因在UNOS数据中未指明。通过从各个移植中心收集患者水平的数据,我们将能够计算这种结果错误分类的程度,从而指导我们在Aim I中的主要模型的定量敏感性分析。最后,我们将评估引入MELD系统进行肝脏分配是否与PSC患者的活体肝移植率相对于无PSC患者的相应比率的变化相关。这项分析是必要的,因为在有和没有PSC的患者中,活体供体移植的转诊率差异可能会影响诊断可能影响目标I结局的程度。拟议的研究项目将在申请人致力于临床流行病学硕士学位的背景下进行,从而在课堂上进行教学式学习,重点关注流行病学的基础知识,研究设计以及研究的统计和分析方法,将增强和指导申请人的研究过程。该项目申请人的长期目标是收集和分析数据,准备出版手稿,并将数据作为未来K奖申请的一部分。 公共卫生相关性:肝移植器官的分配具有重大的公共卫生影响,因为必须决定如何分配稀缺资源。至关重要的是,我们在一个公平的系统内执业,并且不会因疾病状况而使一组患者处于不利地位。如果发现原发性硬化性胆管炎患者在目前的肝脏分配系统中处于不利地位,那么这将成为考虑大规模政策变化以实现更公平的器官移植系统的基础。
英文摘要
DESCRIPTION (provided by applicant): Primary sclerosing cholangitis (PSC) is a chronic liver disease that has no treatment and is an otherwise fatal disease without liver transplantation. Patients with PSC face unique complications as compared to other patients with end-stage liver disease, including cholangiocarcinoma (CCA), cholangitis from biliary strictures, and complications such as colon cancer from concomitant inflammatory bowel disease. The current model for allocation of livers, instituted on February 27th, 2002, relies on a patient's Model for End Stage Liver Disease (MELD) score, which accounts for a patient's serum INR, creatinine, and bilirubin. The MELD score places more weight on the INR and creatinine, although in patients with PSC the bilirubin is disproportionately elevated. This fact, along with the fact that complications such as CCA are not captured by the MELD data elements, leads us to believe that the MELD score may place patients with PSC at a survival disadvantage. If this is true, then this may serve as a basis for a policy change in how livers are allocated. For patients with PSC on the waitlist, their risk of death may be higher for two reasons. Either the risk of death for a given MELD score is higher for patients with PSC, or in patients with PSC, the MELD score rises more slowly, making patients less likely to receive a transplant and thereby exposed for a longer duration to the risks of clinical deterioration and removal from the waitlist. Our first aim will address this primary research question in three ways. We will develop two Cox proportional hazard models, one accounting for all of a patient's MELD scores while on the waitlist, and another adjusting only for MELD at listing. We will also perform logistic regression to evaluate the clinically important outcome of death vs. transplant. Our second aim will serve to determine the frequencies with which potential liver transplant recipients are removed from the waitlist due to clinical deterioration among those in whom the reasons for withdrawal are unspecified in UNOS data. By collecting patient level data from individual transplant centers, we will be able to calculate the extent of this outcome misclassification and thereby guide quantitative sensitivity analyses of our primary models in Aim I. Lastly, we will evaluate whether introduction of the MELD system for liver allocation was associated with changes in rates of living donor liver transplantation among patients with PSC relative to corresponding rates among patients without PSC. This analysis is needed as differential rates of referral for living donor transplant among patients with and without PSC could affect the extent to which diagnosis may influence the outcomes in Aim I. The proposed research project will be in the context of the applicant working towards a Masters of Science in Clinical Epidemiology, whereby didactic learning in the classroom, focusing on fundamentals of epidemiology, study design, and statistical and analytic methods of research will enhance and guide the research process of the applicant. The long-term objectives of the applicant for this project are to collect and analyze the data, prepare manuscripts for publication, and build upon the data as part of a future application for a K award. PUBLIC HEALTH RELEVANCE: The allocation of organs for liver transplantation has major public health implications in that decisions must be made as to how we allocate a scarce resource. It is critical that we practice within a system that is equitable, and does not disadvantage one group of patients as a result of their disease status. If it is found that patients with primary sclerosing cholangitis are disadvantaged by the current liver allocation system, then this will form a foundation for which large-scale policy changes are considered to bring about a fairer system of organ transplantation.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/lt.23394
发表时间: 2012-04
期刊: LIVER TRANSPLANTATION
影响因子: 4.6
作者: [Goldberg, David, French, Benjamin, Abt, Peter, Feng, Sandy, Cameron, Andrew M.]
通讯作者: Cameron, Andrew M.
3/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease
A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)
  • 批准号:
    10605313
  • 项目类别:
  • 资助金额:
    $161.34万
  • 财政年份:
    2021
  • 负责人:
    David Seth Goldberg
  • 依托单位:
海外基金